Clinical trial

Elderly Primary Insomnia Polysomnographic Study (0928-002)(TERMINATED)

NCT00094666 · H. Lundbeck A/S, Industry · Terminated

Key facts

NCT number NCT00094666
Title Elderly Primary Insomnia Polysomnographic Study (0928-002)(TERMINATED)
Official title A Double-Blind, Randomized, Placebo-Controlled, Multicenter, 30-Night Polysomnographic Study of MK0928 in Elderly Patients With Primary Insomnia
Lead sponsor H. Lundbeck A/S, Industry
Status Terminated
Phase Phase 3
Study type Interventional
Conditions Primary Insomnia
Intervention type Drug
Interventions MK0928, gaboxadol / Duration of Treatment - 6 weeks, Comparator: placebo / Duration of Treatment - 6 weeks
Enrollment 465
Start date Nov 1, 2004
Primary completion Mar 1, 2007
Completion Mar 1, 2007
First posted Oct 22, 2004
Last update posted Jan 14, 2015

At a glance

  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies